BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK
133 results:

  • 1. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
    Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
    Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
    Taşçı EŞ; Oyan B; Sönmez Ö; Mutlu AU; Atcı MM; Sakin A; Öner İ; Çınkır HY; Eryılmaz MK; Çağlayan D; Balçık OY; Paksoy N; Karabulut S; Salim DK; Bilir C; Özen M; Özçelik M; Arıcan A; Akagündüz B; İnal A; Aydın D; Özer L; Gülmez A; Turhal NS; Esen SA; Algın E; Akbaş S; İriağaç Y; Şakalar T; Ünal Ç; Er Ö; Seçmeler Ş; Bozkurt M
    BMC Cancer; 2024 Jan; 24(1):16. PubMed ID: 38166764
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cost-Efficient Detection of
    Romanko AA; Mulkidjan RS; Tiurin VI; Saitova ES; Preobrazhenskaya EV; Krivosheyeva EA; Mitiushkina NV; Shestakova AD; Belogubova EV; Ivantsov AO; Iyevleva AG; Imyanitov EN
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762506
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors.
    Normanno N; Machado JC; Pescarmona E; Buglioni S; Navarro L; Esposito Abate R; Ferro A; Mensink R; Lambiase M; Lespinet-Fabre V; Calgua B; Jermann PM; Ilié M; Hofman P
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762091
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Mulkidjan RS; Saitova ES; Preobrazhenskaya EV; Asadulaeva KA; Bubnov MG; Otradnova EA; Terina DM; Shulga SS; Martynenko DE; Semina MV; Belogubova EV; Tiurin VI; Amankwah PS; Martianov AS; Imyanitov EN
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686416
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database.
    Wehrli LA; Reppucci ML; Ketzer J; Dominguez-Muñoz A; Cooper EH; Peña A; Bischoff A; De La Torre L
    Pediatr Surg Int; 2023 Jul; 39(1):227. PubMed ID: 37418029
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Pathological Types,Expression of Mismatch Repair Protein,Human Epidermal Growth Factor Receptor 2,and Pan-trk,and Eostein-Barr Virus Infection in Patients With colorectal cancer Resected in Tibet].
    Luo HH; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Guo PP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):422-428. PubMed ID: 37407529
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel approach toward minimally invasive surgery for mid-transverse colon cancer: 'moving the left colon' technique.
    Iguchi K; Sugano N; Sugiyama A; Saito K; Atsumi Y; Kazama K; Numata M; Mushiake H; Sato T; Rino Y
    Colorectal Dis; 2023 Aug; 25(8):1713-1717. PubMed ID: 37401036
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, trka, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 colorectal cancer Cells.
    Jung EJ; Kim HJ; Shin SC; Kim GS; Jung JM; Hong SC; Kim CW; Lee WS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373014
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ntrk fusions in solid tumours: what every pathologist needs to know.
    Nguyen MA; Colebatch AJ; Van Beek D; Tierney G; Gupta R; Cooper WA
    Pathology; 2023 Aug; 55(5):596-609. PubMed ID: 37330338
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficient Identification of Patients With Ntrk Fusions Using a Supervised Tumor-Agnostic Approach.
    Hernandez S; Conde E; Molero A; Suarez-Gauthier A; Martinez R; Alonso M; Plaza C; Camacho C; Chantada D; Juaneda-Magdalena L; Garcia-Toro E; Saiz-Lopez P; Rojo F; Abad M; Boni V; Del Carmen S; Regojo RM; Sanchez-Frias ME; Teixido C; Paz-Ares L; Lopez-Rios F
    Arch Pathol Lab Med; 2024 Mar; 148(3):318-326. PubMed ID: 37270803
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of surgical outcomes of laparoscopic versus open surgery for locally advanced mid-transverse colon cancer.
    Iguchi K; Numata M; Shiozawa M; Kazama K; Sawazaki S; Katayama Y; Numata K; Higuchi A; Godai T; Sugano N; Mushiake H; Rino Y
    Langenbecks Arch Surg; 2023 Jun; 408(1):222. PubMed ID: 37266706
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Elaboration of Ntrk-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S; Liu Y; Shi X; Zhou W; Zeng X
    Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of Ntrk fusion detection methods in microsatellite-instability-high metastatic colorectal cancer.
    Schraa SJ; Stelloo E; Laclé MM; Swennenhuis JF; Brosens LAA; Fijneman RJA; Feitsma H; Koopman M; de Leng WW; Vink GR; Bol GM
    Virchows Arch; 2023 Jun; 482(6):983-992. PubMed ID: 37067589
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. China special issue on gastrointestinal tumors-Ntrk fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide trk inhibitor treatment.
    Qi C; Zhou T; Bai Y; Chen H; Yuan J; Zhao F; Liu C; Ma M; Bei T; Chen S; Zhao X; Chen C; Shen L
    Int J Cancer; 2023 Dec; 153(11):1916-1927. PubMed ID: 36946696
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis Of Common Somatic Mutations In colorectal Carcinoma And Associated Dysregulated Pathwaysarts.
    Hassan S; Khatoon A; Bukhari U; Mirza T
    J Ayub Med Coll Abbottabad; 2023; 35(1):137-143. PubMed ID: 36849394
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.
    Hua H; He W; Chen N; He Y; Wu G; Ye F; Zhou X; Li Y; Ding Y; Zhong W; Teng L; Jiang W; Sheng Q
    Front Immunol; 2022; 13():974793. PubMed ID: 36700211
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A reciprocal feedback between colon cancer cells and Schwann cells promotes the proliferation and metastasis of colon cancer.
    Han S; Wang D; Huang Y; Zeng Z; Xu P; Xiong H; Ke Z; Zhang Y; Hu Y; Wang F; Wang J; Zhao Y; Zhuo W; Zhao G
    J Exp Clin Cancer Res; 2022 Dec; 41(1):348. PubMed ID: 36522730
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prevalence of Ntrk Fusions in Canadian Solid Tumour cancer Patients.
    Silvertown JD; Lisle C; Semenuk L; Knapp C; Jaynes J; Berg D; Kaul N; Lachapelle J; Richardson L; Speevak M; Sarras H; Berman DM; Carter R; Feilotter H; Feltis T
    Mol Diagn Ther; 2023 Jan; 27(1):87-103. PubMed ID: 36194351
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Treatment Patterns of Real-World Patients with trk Fusion cancer Treated by US Community Oncologists.
    Klink AJ; Kavati A; Gassama A; Kozlek T; Gajra A; Antoine R
    Target Oncol; 2022 Sep; 17(5):549-561. PubMed ID: 36089643
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.